5 results for author:"Mucilli F." in Literature citations
Results Customize
› Repeat search in UniProtKB (2)
| Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations. Marchetti A., Felicioni L., Malatesta S., Grazia Sciarrotta M., Guetti L., Chella A., Viola P., Pullara C., Mucilli F., Buttitta F. J. Clin. Oncol. 29:3574-3579(2011) · Mapped (3) |
| Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung. Marchetti A., Felicioni L., Pelosi G., Del Grammastro M., Fumagalli C., Sciarrotta M., Malatesta S., Chella A., Barassi F., Mucilli F. et al. |
| Int6 expression can predict survival in early-stage non-small cell lung cancer patients. Buttitta F., Martella C., Barassi F., Felicioni L., Salvatore S., Rosini S., D'Antuono T., Chella A., Mucilli F., Sacco R. et al. Clin. Cancer Res. 11:3198-3204(2005) · Mapped (4) |
| Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome. Marchetti A., Barassi F., Martella C., Chella A., Salvatore S., Castrataro A., Mucilli F., Sacco R., Buttitta F. Clin. Cancer Res. 10:1338-1343(2004) · Mapped (1) |
| Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients. Marchetti A., Tinari N., Buttitta F., Chella A., Angeletti C.A., Sacco R., Mucilli F., Ullrich A., Iacobelli S. Cancer Res. 62:2535-2539(2002) · Mapped (6) |